3 June 2025
Chromatography resins: Innovation for the healthcare industry
Modern healthcare places the highest demands on the purity, safety, and efficiency of biopharmaceutical products. Nordmann partner Sunresin New Materials Co., Ltd., a leading global supplier of ion exchange and adsorption resins, offers a powerful solution to the complex challenges of the biotechnology and pharmaceutical industries with its chromatographic separation agents.
Specialized resins for biopharmaceutical applications
Sunresin has developed a wide range of SEPLIFE® chromatography resins that are specifically tailored to the requirements of the life sciences and healthcare industries.
These include:
- Multimodal chromatography resins (e.g., Seplife Suncore 400/700): These resins enable flow-controlled purification of sensitive biological products such as:
- Virus vaccines (e.g., influenza, rabies)
- Virus-like particles (VLPs) for vaccines such as hepatitis B
- Viral vectors for gene and cell therapies (e.g., AAV, lentiviruses)
- Plasmid DNA (pDNA) for nucleic acid therapeutics
- Exosomes and nanocarriers for innovative drug delivery
These resins are characterized by selective retention of contaminants such as host cell proteins (HCP), DNA, endotoxins, and other process contaminants, while allowing the target molecule to pass through unimpeded.
For more information, please contact:
Kathrin Aicher
Technical Sales & Product Manager | Health Care
Nordmann, Rassmann GmbHBenefits for the healthcare industry
- High purity and yield: Optimized separation performance for sensitive biomolecules.
- Scalability: Suitable for research, clinical trials, and commercial production.
- Regulatory compliance: Production according to ISO 9001:2015 and ISO 14001:2015 standards.
- Customized solutions: Close collaboration with pharmaceutical companies to develop tailor-made processes.
Innovation and global presence
With over 70 patents, five highly automated production facilities, and a global network of R&D and application experts, Sunresin is a strategic partner for companies in biopharmaceutical development and production.
Distributed in:
Germany and Switzerland.
4 June 2025
High-quality excipients for the pharmaceutical industry
For the manufacture of pharmaceutical dosage forms, Nordmann partners with Ingredion Pharma Solutions which has realigned and refocused its activities on high-quality, compendial excipients. These pharmaceutical excipients meet strict quality standards and are described in official monographs such as the European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopeia (USP-NF).
3 June 2025
Chromatography resins: Innovation for the healthcare industry
Modern healthcare places the highest demands on the purity, safety, and efficiency of biopharmaceutical products. Nordmann partner Sunresin New Materials Co., Ltd., a leading global supplier of ion exchange and adsorption resins, offers a powerful solution to the complex challenges of the biotechnology and pharmaceutical industries with its chromatographic separation agents.
26 May 2025
Double Layer Tablets from Cell Biotech: Innovation and Quality
Nordmann partner Cell Biotech has made a name for itself with 30 years of experience in the manufacture of chewable tablets. The Double Layer Tablets are an outstanding example of technological innovation and quality. These two-layer tablets combine different active ingredients and offer numerous benefits for consumers of all ages.
